ArticleFrontiers in immunology2023

Host-specific differences in top-expanded TCR clonotypes correlate with divergent outcomes of anti-PD-L1 treatment in responders versus non-responders.

Jessy John et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.